Efficacy and limitations of f-18-fluoro-2-deoxy-d-glucose positron emission tomography to differentiate between malignant and benign bone and soft tissue tumors
S Miwa, T Mochizuki, N Yamamoto, T Shirai… - Anticancer …, 2018 - ar.iiarjournals.org
Background/Aim: Positron emission tomography (PET) using 18fluorine-labelled
fluorodeoxyglucose (FDG), is the most widely applied molecular imaging technique in …
fluorodeoxyglucose (FDG), is the most widely applied molecular imaging technique in …
Feasibility and pitfall of PET/CT scan in assessment of bone and soft-tissue tumors. Initial experiences and literature review
K Suga, K Chagawa, N Seki, T Taguchi… - Rinsho …, 2011 - inis.iaea.org
[en] In the assessment of bone and soft-tissue tumors, morphologic MRI and CT imaging has
been widely used. Metabolic imaging with Fluorodeoxyglucose (FDG) positron emission …
been widely used. Metabolic imaging with Fluorodeoxyglucose (FDG) positron emission …
Usefulness of FDG PET in primary bone tumors
T Yanagawa, H Watanabe, T Shinozaki… - The Open Bone …, 2010 - benthamopen.com
Positron emission tomography (PET) using [18F] fluorodeoxyglucose (FDG) is a useful
modality to examine many kinds of tumors, including primary bone tumors. Malignant bone …
modality to examine many kinds of tumors, including primary bone tumors. Malignant bone …
FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions
J Aoki, H Watanabe, T Shinozaki, K Takagishi… - Radiology, 2001 - pubs.rsna.org
PURPOSE: To evaluate the standardized uptake value (SUV) of 2-[fluorine-18] fluoro-2-
deoxy-d-glucose (FDG) at positron emission tomography (PET) in the differentiation of …
deoxy-d-glucose (FDG) at positron emission tomography (PET) in the differentiation of …
Fluorodeoxyglucose positron emission tomography of soft tissue tumours: is a non-invasive determination of biological activity possible?
M Schulte, D Brecht-Krauss, B Heymer… - European journal of …, 1999 - Springer
Since musculoskeletal tumours comprise a large heterogeneous group of entities with
different biological behaviour, clinical diagnosis of such lesions can be very difficult. The aim …
different biological behaviour, clinical diagnosis of such lesions can be very difficult. The aim …
FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases
M Charest, M Hickeson, R Lisbona… - European journal of …, 2009 - Springer
Purpose The aims of this study are to evaluate the sensitivity of FDG PET/CT for detection of
soft tissue and osseous sarcomas on the basis of FDG avidity. Methods We retrospectively …
soft tissue and osseous sarcomas on the basis of FDG avidity. Methods We retrospectively …
[HTML][HTML] FDG–PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging
C Franzius, HE Daldrup-Link, A Wagner-Bohn, J Sciuk… - Annals of oncology, 2002 - Elsevier
Background The aim of this study was to assess the diagnostic ability of positron emission
tomography using 2-[fluorine-18] fluoro-2-deoxy-d-glucose (FDG–PET) in the detection of …
tomography using 2-[fluorine-18] fluoro-2-deoxy-d-glucose (FDG–PET) in the detection of …
Clinical value of [18-F] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas
MHM Schwarzbach, A Dimitrakopoulou-Strauss… - Annals of …, 2000 - journals.lww.com
Clinical Value of [18-F] Fluorodeoxyglucose Positron Emissio... : Annals of Surgery Clinical Value
of [18-F] Fluorodeoxyglucose Positron Emission Tomography Imaging in Soft Tissue Sarcomas …
of [18-F] Fluorodeoxyglucose Positron Emission Tomography Imaging in Soft Tissue Sarcomas …
FDG-PET for preoperative differential diagnosis between benign and malignant soft tissue masses
J Aoki, H Watanabe, T Shinozaki, K Takagishi… - Skeletal radiology, 2003 - Springer
Objective To evaluate the standardized uptake value (SUV) of [18 F] 2-deoxy-2-fluoro-d-
glucose at positron emission tomography (FDG-PET) for preoperative differential diagnosis …
glucose at positron emission tomography (FDG-PET) for preoperative differential diagnosis …
FDG-PET for evaluating musculoskeletal tumors: a review
J Aoki, K Endo, H Watanabe, T Shinozaki… - Journal of Orthopaedic …, 2003 - Springer
Positron-emission tomography (PET) can provide an in vivo method for evaluating
metabolism and physiology in normal and diseased tissues. Clinical trials with [18 F] 2 …
metabolism and physiology in normal and diseased tissues. Clinical trials with [18 F] 2 …